These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22451576)

  • 1. Background parenchymal enhancement on breast MRI: impact on diagnostic performance.
    DeMartini WB; Liu F; Peacock S; Eby PR; Gutierrez RL; Lehman CD
    AJR Am J Roentgenol; 2012 Apr; 198(4):W373-80. PubMed ID: 22451576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up.
    Hambly NM; Liberman L; Dershaw DD; Brennan S; Morris EA
    AJR Am J Roentgenol; 2011 Jan; 196(1):218-24. PubMed ID: 21178070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices.
    Ray KM; Kerlikowske K; Lobach IV; Hofmann MB; Greenwood HI; Arasu VA; Hylton NM; Joe BN
    Radiology; 2018 Mar; 286(3):822-829. PubMed ID: 29072981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revisiting Nonmass Enhancement in Breast MRI: Analysis of Outcomes and Follow-Up Using the Updated BI-RADS Atlas.
    Chikarmane SA; Michaels AY; Giess CS
    AJR Am J Roentgenol; 2017 Nov; 209(5):1178-1184. PubMed ID: 28834447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Menstrual Cycle Timing on Screening Breast MRI Background Parenchymal Enhancement and Diagnostic Performance in Premenopausal Women.
    Dontchos BN; Rahbar H; Partridge SC; Lehman CD; DeMartini WB
    J Breast Imaging; 2019 Sep; 1(3):205-211. PubMed ID: 31538142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Background parenchymal enhancement in breast MRIs of breast cancer patients: impact on tumor size estimation.
    Baek JE; Kim SH; Lee AW
    Eur J Radiol; 2014 Aug; 83(8):1356-62. PubMed ID: 24882786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.
    Kim SY; Lee HS; Kim EK; Kim MJ; Moon HJ; Yoon JH
    Ultrasound Med Biol; 2016 Dec; 42(12):2766-2774. PubMed ID: 27658753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motion artifacts, lesion type, and parenchymal enhancement in breast MRI: what does really influence diagnostic accuracy?
    Clauser P; Dietzel M; Weber M; Kaiser CG; Baltzer PA
    Acta Radiol; 2019 Jan; 60(1):19-27. PubMed ID: 29667880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Malignancy and Imaging Characteristics of Probably Benign Lesions Seen at Breast MRI.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 Aug; 205(2):442-7. PubMed ID: 26204298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
    Seely JM; Nguyen ET; Jaffey J
    Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.
    Koo HR; Moon WK; Chun IK; Eo JS; Jeyanth JX; Chang JM; Cho N; Kang KW
    Eur J Radiol; 2013 Oct; 82(10):1738-42. PubMed ID: 23806533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-breast US following mammography and breast MRI in newly diagnosed breast cancer patients: can it be more than just a guidance tool for biopsy?
    Park YJ; Kim MJ; Moon HJ; Kim EK; Yoon JH
    Clin Radiol; 2017 May; 72(5):425.e1-425.e7. PubMed ID: 27712905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
    Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
    Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis?
    Taron J; Fleischer S; Preibsch H; Nikolaou K; Gruber I; Bahrs S
    Eur Radiol; 2019 Mar; 29(3):1187-1193. PubMed ID: 30229271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
    Grimm LJ; Anderson AL; Baker JA; Johnson KS; Walsh R; Yoon SC; Ghate SV
    AJR Am J Roentgenol; 2015 May; 204(5):1120-4. PubMed ID: 25905951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
    Chikarmane SA; Tai R; Meyer JE; Giess CS
    Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
    Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
    Sippo DA; Rutledge GM; Burk KS; Mercaldo SF; Dontchos BN; Edmonds CE; Lehman CD
    AJR Am J Roentgenol; 2019 Mar; 212(6):1412-1418. PubMed ID: 30888867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI.
    Morakkabati-Spitz N; Leutner C; Schild H; Traeber F; Kuhl C
    Eur Radiol; 2005 Sep; 15(9):2010-7. PubMed ID: 15841382
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.